
High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Size: Market Cap wise it is among the top 20% companies of india.
Balance Sheet: Strong Balance Sheet.
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Profitability: Recent profitability of 12% is a good sign.
Past Returns: In past three years, the stock has provided 4.8% return compared to 8.9% by NIFTY 50.
Valuation | |
|---|---|
| Market Cap | 27.12 kCr |
| Price/Earnings (Trailing) | 67.29 |
| Price/Sales (Trailing) | 7.83 |
| EV/EBITDA | 42.04 |
| Price/Free Cashflow | 182.6 |
| MarketCap/EBT | 51.13 |
| Enterprise Value | 26.9 kCr |
Fundamentals | |
|---|---|
| Revenue (TTM) | 3.46 kCr |
| Rev. Growth (Yr) | 12.8% |
| Earnings (TTM) | 401.84 Cr |
| Earnings Growth (Yr) | -15.3% |
Profitability | |
|---|---|
| Operating Margin | 15% |
| EBT Margin | 15% |
| Return on Equity | 13.51% |
| Return on Assets | 10.86% |
| Free Cashflow Yield | 0.55% |
Growth & Returns | |
|---|---|
| Price Change 1W | 1.9% |
| Price Change 1M | 2.5% |
| Price Change 6M | 14.4% |
| Price Change 1Y | 15.8% |
| 3Y Cumulative Return | 4.8% |
| 5Y Cumulative Return | 22.3% |
| 7Y Cumulative Return | 25.8% |
| 10Y Cumulative Return | 20.7% |
Cash Flow & Liquidity | |
|---|---|
| Cash Flow from Investing (TTM) | -404.28 Cr |
| Cash Flow from Operations (TTM) | 445.59 Cr |
| Cash Flow from Financing (TTM) | -278.97 Cr |
| Cash & Equivalents | 217.47 Cr |
| Free Cash Flow (TTM) | 148.52 Cr |
| Free Cash Flow/Share (TTM) | 19.74 |
Balance Sheet | |
|---|---|
| Total Assets | 3.7 kCr |
| Total Liabilities | 785.76 Cr |
| Shareholder Equity | 2.97 kCr |
| Current Assets | 2.07 kCr |
| Current Liabilities | 689.17 Cr |
| Net PPE | 1.22 kCr |
| Inventory | 788.26 Cr |
| Goodwill | 181.31 Cr |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.00 |
| Debt/Equity | 0.00 |
| Interest Coverage | 142.35 |
| Interest/Cashflow Ops | 121.43 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 36 |
| Dividend Yield | 1.1% |
| Shares Dilution (1Y) | 0.00% |
| Shares Dilution (3Y) | 0.00% |
Size: Market Cap wise it is among the top 20% companies of india.
Balance Sheet: Strong Balance Sheet.
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Profitability: Recent profitability of 12% is a good sign.
Past Returns: In past three years, the stock has provided 4.8% return compared to 8.9% by NIFTY 50.
Investor Care | |
|---|---|
| Dividend Yield | 1.1% |
| Dividend/Share (TTM) | 36 |
| Shares Dilution (1Y) | 0.00% |
| Earnings/Share (TTM) | 53.58 |
Financial Health | |
|---|---|
| Current Ratio | 3 |
| Debt/Equity | 0.00 |
Technical Indicators | |
|---|---|
| RSI (14d) | 59.47 |
| RSI (5d) | 59.46 |
| RSI (21d) | 53.81 |
| MACD Signal | Buy |
| Stochastic Oscillator Signal | Hold |
| SharesGuru Signal | Buy |
| RSI Signal | Hold |
| RSI5 Signal | Hold |
| RSI21 Signal | Hold |
| SMA 5 Signal | Sell |
| SMA 10 Signal | Buy |
| SMA 20 Signal | Buy |
| SMA 50 Signal | Buy |
| SMA 100 Signal | Buy |
Summary of Timken India's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
Management's outlook for Timken India Limited indicates a strong performance trajectory despite macroeconomic challenges. In Q4 FY26, the company crossed INR 1,000 crores in quarterly revenue for the first time, achieving INR 10,731 million in revenue from operations, which reflects a 14.2% year-over-year growth. The profit before tax (PBT) for the quarter was reported at INR 2,074 million, with a PBT margin of 19.3%.
For the full fiscal year, consolidated revenue from operations stood at INR 34,780 million, with a PBT of INR 5,526 million, marking a slight increase of 3% from the previous year. The company reported a robust cash generation of INR 4,374 million, and capital investments totaled INR 2,972 million, representing 8.7% of revenue.
Key forward-looking points highlighted by management include:
When questioned about future revenue expectations, management expressed aspirations to outpace market growth while avoiding specific percentage guidance for FY27, emphasizing a focus on strategic execution and efficiency gains.
Here is a summary of the key Q&A from the earnings transcript:
1. Ankur Sharma: "In terms of price hikes, how much have you already tried to take? How much more needs to be taken?"
Sanjay Koul: We have begun passing on cost increases, currently at about 10%. Our strategy to achieve further price recovery has started since mid-April. We aim to pass on the remaining 90% in the next two quarters. It's challenging with OEM customers, but we hope for retrospective adjustments.
2. Ankur Sharma: "How do you see growth in the domestic rail and CV market, and exports, especially to the U.S.?"
Sanjay Koul: Exports grew significantly, with Q4 bringing in INR222 crores, a 66% year-over-year increase. Rail markets are slow but stable, and CV markets remain robust, with domestic consumption still strong despite inflationary pressures.
3. Ankur Sharma: "What is the current utilization of the Bharuch factory, and what are the targets?"
Sanjay Koul: The Bharuch plant has capitalized on all lines, generating INR80 crores in revenue the last fiscal year. We currently run full capacity on smaller lines and aim for 70% utilization by July, with plans to ramp up based on more PPAPs.
4. Varun Jain: "Can you share segmental revenue for Q4 and FY26?"
Sanjay Koul: For Q4 FY26, revenue breakdown was: Rail INR278 crores (26%), Mobile (CV and tractors) INR205 crores (19%), Distribution INR162 crores (15%), Process INR200 crores (19%), and Intercompany INR222.5 crores (21%). Total for FY26 was INR3,419 crores.
5. Varun Jain: "What is the capex for the Jamshedpur expansion, and when do you expect to go live?"
Sanjay Koul: We expect to begin production by December 2026, with a capex of approximately INR120 crores. We anticipate asset turns of around 2x as we ramp up production.
6. Rishi Vora: "What is the ramp-up expectation for the CRB and SRB plant in FY27?"
Sanjay Koul: We project utilization to increase to about 70% by July, with further improvement as customer approvals continue. Revenue potential will depend significantly on the customer mix.
7. Raghunandhan NL: "Any revisions in capex guidance for the next three years?"
Sanjay Koul: We may adjust capex based on market dynamics and potential M&A opportunities. Our commitement remains around 8% to 10% of revenue annually, and we are free to invest if attractive projects arise.
These summaries encapsulate the key questions and responses along with important metrics and projections shared during the Q&A section of the earnings call.
Understand Timken India ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| Timken Singapore Pte Ltd | 51.05% |
| Hdfc Mutual Fund - Hdfc Mid-Cap Fund | 7.94% |
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund | 4.12% |
| Sbi Large & Midcap Fund | 3.78% |
| Invesco India Business Cycle Fund | 2.24% |
| Mirae Asset Large Cap Fund | 1.86% |
| Icici Prudential Smallcap Fund | 1.57% |
| Investor Education And Protection Fund Authority Ministry Of Corporate Affairs | 1.36% |
| Tata Aia Life Insurance Co Ltd-Whole Life Mid Cap Equity Fund-Ulif 009 04/01/07 Wle 110 | 1.15% |
| Hdfc Life Insurance Company Limited | 1.04% |
Distribution across major stakeholders
Distribution across major institutional holders
Detailed comparison of Timken India against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| SCHAEFFLER | Schaeffler India | 65.59 kCr | 10.24 kCr | -2.10% | +4.90% | 53.39 | 6.4 | - | - |
| SKFINDIA | SKF India | 8.46 kCr | 3.87 kCr | +0.50% | -62.40% | 31.83 | 2.19 | - | - |
| NRBBEARING | NRB Bearings | 3.73 kCr | 1.37 kCr | +36.10% | +42.80% | 26.13 | 2.72 | - | - |
| MENONBE | Menon Bearings | 831.69 Cr | 300.24 Cr | +25.40% | +25.70% | 21.76 | 2.77 | - | - |
Comprehensive comparison against sector averages
TIMKEN metrics compared to Industrial
| Category | TIMKEN | Industrial |
|---|---|---|
| PE | 67.29 | 39.15 |
| PS | 7.83 | 2.79 |
| Growth | 8.3 % | 9.9 % |
Timken India Limited manufactures and distributes tapered roller bearings, other roller bearings, components, and accessories for the automotive sector and railway industry in India, the United States, and internationally. The company offers cylindrical roller, plain, spherical roller, tapered roller, thrust, precision, slewing, and ball bearing, as well as seals, maintenance tools, housed units, and wheel hub under the Timken brand; and integrated bearing assemblies, driveline center support bearings for commercial and light vehicles, and lubrication and lubrication systems. It provides mechanical power transmission products, such as encoders, gear boxes/transmissions, couplings and joints, belts, augers, linear motion products, brakes and clutches, commercial vehicles wheels and accessories and tools, and chains. In addition, the company offers maintenance contract and refurbishment services; and uptower and motor repair services. Timken India Limited was formerly known as Tata Timken Limited and changed its name to Timken India Limited in July 1999. The company was incorporated in 1987 and is based in Bengaluru, India. Timken India Limited operates as a subsidiary of The Timken Company.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
TIMKEN vs Industrial (2021 - 2026)